ACLARIS THERAPEUTICS, INC.

ACRS US00461U1051

🆔
Registration No.
5183695
💰
Capitalization
Small-cap

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases. The contract research segment earns revenue from the provision of laboratory services. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.

🏢
Founded
2012
🔗
Website
https://www.aclaristx.com
Annual Performance 1
2021 2022 2023 2024 2025
124% 8% -93% 136% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
24
🙍
Insiders
3
Person Price Shares Total Published Completed
Mehra Anand
O 		2.25
USD 		666,666
Bought 		1,499,999
USD 		19/11/2024 19/11/2024
Leonard Braden Michael
 1.24
USD 		206,025
Bought 		256,357
USD 		02/08/2024 05/08/2024
Leonard Braden Michael
 1.29
USD 		167,544
Bought 		216,400
USD 		02/08/2024 02/08/2024
Leonard Braden Michael
 1.33
USD 		100,000
Bought 		132,640
USD 		30/07/2024 31/07/2024
Leonard Braden Michael
 1.30
USD 		173,730
Bought 		226,370
USD 		30/07/2024 30/07/2024
Leonard Braden Michael
 1.33
USD 		17,716
Bought 		23,557
USD 		18/07/2024 22/07/2024
Leonard Braden Michael
 1.30
USD 		6,689
Bought 		8,696
USD 		18/07/2024 19/07/2024
Leonard Braden Michael
 1.30
USD 		130,317
Bought 		169,555
USD 		18/07/2024 18/07/2024
Leonard Braden Michael
 1.15
USD 		123,017
Bought 		141,334
USD 		02/07/2024 05/07/2024
Leonard Braden Michael
 1.16
USD 		143,288
Bought 		166,071
USD 		02/07/2024 03/07/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include ACLARIS THERAPEUTICS, INC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
114% 88% 84% -73% 12% -90% -91%
Last 52W Low 52W High All-Time Low All-Time High β
1.84 1.08 4.59 0.64 32.99
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Leonard Braden Michael 21 5,591,647.10 266,268.91 11/06/2024 05/08/2024
Mehra Anand 1 1,499,998.50 1,499,998.50 19/11/2024 19/11/2024
Powell Andrew Kenneth William 2 17,955.00 8,977.50 01/03/2024 04/03/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.